Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Cash Flows

v3.21.4
Consolidated Statement of Cash Flows
 4 Months Ended
Dec. 31, 2020
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (22,494,229)
Adjustments to reconcile net loss to net cash used in operating activities:  
Change in fair value of warrant liabilities 19,728,480
General and administrative expenses paid through Note from Sponsor 130,377
Loss on initial issuance of warrants 1,654,000
Transaction costs allocated to warrant liability 787,138
Interest earned on securities held in Trust Account (32,171)
Changes in operating assets and liabilities:  
Prepaid expenses (662,865)
Accounts payable 44,898
Accrued expenses 33,446
Franchise tax payable 65,481
Net cash used in operating activities (745,445)
Cash Flows from Investing Activities  
Cash deposited in Trust Account (237,276,000)
Net cash used in investing activities (237,276,000)
Cash Flows from Financing Activities:  
Proceeds from note payable to related party 44,500
Repayment of note payable to related party (289,713)
Proceeds received from initial public offering, gross 237,250,000
Proceeds received from private placement 6,771,000
Offering costs paid (4,419,175)
Net cash provided by financing activities 239,356,612
Net change in cash 1,335,167
Cash - beginning of the period
Cash - end of the period 1,335,167
Supplemental disclosure of noncash financing activities:  
Offering costs paid by Sponsor in exchange for issuance of Class A and Class B common stock 25,000
Non-controlling interest in subsidiary 1,000
Offering costs included in accounts payable 173,020
Offering costs included in accrued expenses 85,000
Offering costs funded with note payable - related party 114,836
Deferred legal fees 187,500
Deferred underwriting commissions 7,610,750
Initial classification of warrant liability $ 21,206,020